Skip to main content
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc. — Investor Relations & Filings

Ticker · PRAX ISIN · US74006W2070 US Manufacturing
Open in API
Filings indexed 458 across all filing types
Latest filing 2021-04-15 Board/Management Inform…
Country US United States of America
Listing US PRAX

About Praxis Precision Medicines, Inc.

https://praxismedicines.com/

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company that develops therapies for central nervous system (CNS) disorders. The company's methodology involves translating insights from genetic epilepsies into treatments for conditions characterized by neuronal excitation-inhibition imbalance. Praxis employs a genetics-focused approach, utilizing translational tools and patient-guided development strategies to advance its portfolio. The developmental pipeline includes several clinical-stage assets and numerous early-stage programs designed to address complex brain disorders.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated April 13, 2021. The content focuses on changes in the company's board of directors: two directors resigned and one new director was elected. There is no financial data, earnings information, or other report content. The primary subject is the announcement of board member changes, which fits the category of Board/Management Information (MANG). The document length is 4724 characters, which is sufficient to contain detailed information about the board changes. Therefore, the appropriate classification is MANG with high confidence.
2021-04-15 English
Regulatory Filings 2021
Regulatory Filings Classification · 60% confidence The provided document text appears to be heavily encoded or corrupted, containing no readable or meaningful content related to financial reporting, regulatory announcements, or corporate filings. There are no identifiable keywords, regulatory references, fiscal period dates, or document titles that would allow classification into any specific filing category. Given the lack of substantive content and the fallback rule for documents that do not fit any category, the appropriate classification is Regulatory Filings (RNS). The confidence is moderate due to the inability to extract meaningful information but the clear absence of any other identifiable filing type.
2021-03-19 English
Capital/Financing Update 2021
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed confidentially with the SEC by Praxis Precision Medicines, Inc. It is a registration statement under the Securities Act of 1933, used for initial public offerings or other securities offerings. The text includes detailed information about the offering, company overview, risk factors, use of proceeds, underwriting, and other typical prospectus content. It is not an annual report, earnings release, or any other financial report type. It is a capital markets filing related to fundraising and securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is a full registration statement, not a brief announcement or certification, so it is not RNS or RPA.
2021-03-18 English
FORM S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option and employee stock purchase plans. It includes details about the number of shares registered, the plans under which they are issued, and legal exhibits. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a report publication notice but a full registration statement.
2021-03-17 English
10-K
Annual Report FY 2020
2021-03-17 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 17, 2021, by Praxis Precision Medicines, Inc. It announces the company's financial results for the quarter and full year ended December 31, 2020. The text mentions a press release and presentation slides attached as exhibits, which are typical for earnings announcements. The document itself is a current report providing initial financial results and business updates, consistent with an Earnings Release. The document length is 3762 characters, which is short and includes the announcement and exhibits but not detailed financial statements or analysis, fitting the definition of an Earnings Release rather than a full Interim/Quarterly Report or Annual Report. Therefore, the appropriate classification is Earnings Release (ER).
2021-03-17 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.